United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - butalbital and acetaminophen tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product. - patients with porphyria. abuse and dependence: butalbital: barbiturates may be habit-forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occur

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - metolazone tablets are indicated for the treatment of salt and water retention including: - edema accompanying congestive heart failure; - edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. metolazone tablets are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. a dose titration is necessary if mykrox tablets are to be substituted for metolazone in the treatment of hypertension. see package circular for mykrox tablets. usage in pregnancy the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia. edema

United States - English - NLM (National Library of Medicine)

hameln pharmaceuticals - pentetate zinc trisodium (unii: nxu65ic8pg) (pentetic acid - unii:7a314hqm0i) - injection, solution, concentrate - 200 mg in 1 ml - zn-dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. none known.

United States - English - NLM (National Library of Medicine)

hameln pharma gmbh - pentetate zinc trisodium (unii: nxu65ic8pg) (pentetic acid - unii:7a314hqm0i) - pentetate zinc trisodium 1000 mg in 5 ml - zn-dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. none. pregnancy category b risk summary there are no adequate and well-controlled studies of zn-dtpa use in pregnant women. chelation treatment of pregnant women should begin and continue with zn-dtpa. reproduction studies have been performed in pregnant mice at doses up to 31 times (11.5 mmol/kg) the recommended daily human dose and have revealed no evidence of impaired fertility or harm to the fetus due to zn-dtpa. there was a slight reduction in the average birth weight. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. it is not known whether zn-dtpa is excreted in human milk. radiocontaminants are known to be excreted in breast milk. women with known or suspected internal contamination with radiocontaminants should not breast feed, whether

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - sennosides (unii: 3fyp5m0ijx) (sennosides - unii:3fyp5m0ijx) - laxative - relieves occasional constipation (irregularity) - this product generally produces a bowel movement in 6 to 12 hours

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - hypertonicity agent for temporary relief of corneal edema. you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag), sennosides (unii: 3fyp5m0ijx) (sennosides - unii:3fyp5m0ijx) - stool softener stimulant laxative - relieves occasional constipation (irregularity) - generally produces bowel movement in 6 to 12 hours

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - mineral oil (unii: t5l8t28fgp) (mineral oil - unii:t5l8t28fgp), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - lubricant - for the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind and sun. - may be used as a protectant against further irritation. - you feel eye pain. - changes in vision occur. - redness or irritation of the eye(s) gets worse, persists or lasts more than 72 hours.

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - mineral oil (unii: t5l8t28fgp) (mineral oil - unii:t5l8t28fgp), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - emollient - for the temporary relief of discomfort due to minor irritations.

United States - English - NLM (National Library of Medicine)

aace pharmaceuticals, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - pain reliever stop use and ask a doctor if - an allergic reaction occurs. seek medical help right away. - you are experierance any of the following signs of stomach bleeding: feel faint, have bloody or black stools, vomit blood, have stomach pain that does not get better - pain gets worse or lasts more than 10 days - redness or swelling is present - new symptoms occur - ringing in the ears or a loss of hearing occurs. these could be signs of a serious condition. pin reliever